Rating History for Heron Therapeutics (HRTX) by Guggenheim
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/27/2020 | Dana Flanders | New Coverage | Buy (N/A) |
24.00 (N/A) |
18.24 (2.59) |
-85.8% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/27/2020 | Dana Flanders | New Coverage | Buy (N/A) |
24.00 (N/A) |
18.24 (2.59) |
-85.8% | Details |
